tiprankstipranks
Advertisement
Advertisement
VolitionRX Earnings Call Balances Breakthroughs and Risks
PremiumCompany AnnouncementsVolitionRX Earnings Call Balances Breakthroughs and Risks
1M ago
Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications
Premium
Ratings
Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications
1M ago
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk
Premium
Company Announcements
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk
2M ago
VolitionRx Enacts One-for-Twenty Reverse Stock Split
PremiumCompany AnnouncementsVolitionRx Enacts One-for-Twenty Reverse Stock Split
2M ago
Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested
2M ago
VolitionRx’s compliance plan accepted by NYSE American
Premium
The Fly
VolitionRx’s compliance plan accepted by NYSE American
2M ago
VolitionRx price target lowered to $1 from $1.50 at H.C. Wainwright
PremiumThe FlyVolitionRx price target lowered to $1 from $1.50 at H.C. Wainwright
3M ago
VolitionRx Shareholders Approve Stock Issuance and Reverse Split
Premium
Company Announcements
VolitionRx Shareholders Approve Stock Issuance and Reverse Split
3M ago
Is VNRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is VNRX a Buy, Before Earnings?
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100